Company intelligence / Profile preview

Elephas

Madison, Wisconsin, United Stateselephas.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Elephas is developing a diagnostics platform that predicts patient response to immunotherapy using metabolic imaging. The platform analyzes tumor architecture via patient biopsies and tests them against potential therapies to determine treatment response. Currently, they have at least one clinical trial recruiting patients to validate their platform.

Therapeutic areas: Oncology
Modalities: Diagnostic platform
Industry: Pathology

Partnerships

Mayo Clinic

Beyond the preview

Go deeper on Elephas.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elephas.

Explore the full profile